Clinic News

Latest in Cardiology

Class I Recalls of Cardiovascular Devices
What are Class I Food and Drug Administration (FDA) recalls of cardiovascular devices and what is the clinical evidence supporting authorization?
Recurrent Rejection in Pediatric Heart Transplantation
What is the prevalence and impact of recurrent rejection (RR) on cardiac allograft vasculopathy (CAV) and graft loss after pediatric heart transplant?
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial
The goal of the EAST-AFNET 4 trial was to compare a rhythm-control strategy vs. usual care (rate control in the majority of cases) among patients with a recent diagnosis of atrial fibrillation (AF).
Assessment of Primary Prevention Patients Receiving an ICDâ€“Systematic Evaluation of ATP
The goal of the APPRAISE ATP trial was to determine the efficacy of antitachycardia pacing (ATP) in terminating ventricular tachycardia (VT) compared with a shock-only strategy in patients with a primary prevention implantable cardioverter-defibrillator (ICD).
ACC CardiaCast: 2024 Update to the AHA/ACC HCM Guideline: Focus on Early Diagnosis and New and Emerging Treatments
In this episode of CardiaCast, hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez will discuss with Dr. Michelle Kittleson recommendations for early diagnosis in the 2024 HCM guideline and review the latest clinical and real-world trial data for new (mavacamten) and emerging (aficamten) cardiac myosin inhibitors.
ACC/AHA Statement Details Work to Optimize Guidelines
A new multisocietal statement details the ACC and American Heart Association (AHA's) work over the last several years to optimize clinical practice guidelines, and outlines the continued work and vision for guideline optimization.
Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure
The goal of the FINEARTS-HF trial was to determine the efficacy and safety of the nonsteroidal mineralocorticoid antagonist finerenone in patients with heart failure (HF) with preserved or mildly reduced left ventricular ejection fraction (LVEF).
Bivalirudin vs. Heparin Anticoagulation in STEMI
What are the outcomes of bivalirudin vs. heparin anticoagulation during percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI)?
HF Risk Assessment Using Biomarkers in Patients With AF
What is the value of specific biomarkers for heart failure (HF) risk stratification in patients with atrial fibrillation (AF)?
Safety and Efficacy of Renal Denervation in Patients With Hypertension: RADIANCE II Trial
Renal denervation (RDN) is an adjunct treatment for hypertension (HTN) that involves catheter ablation of the sympathetic plexus in the adventitia of the renal arteries using radiofrequency (RF) or ultrasound waves.